Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TAGAMET HB 200

CIMETIDINE

Standard Dose
200MG/20ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TAGAMET HB 200 is listed in Drugs@FDA under application 020951 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CIMETIDINE Form and strength SUSPENSION;ORAL - 200MG/20ML Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2000-07-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview TAGAMET HB 200 is listed in Drugs@FDA under application 020951 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CIMETIDINE Form and strength SUSPENSION;ORAL - 200MG/20ML Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2000-07-28 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.